Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-Label Placebo for Non-specific Pain in the Emergency Department
NCT06408519Completed
- Start
- May 2024
- Primary completion
- Feb 2026
- Countries
- 1
01
Overview
Randomised, open-label trial of Placebo-COD Research Private Ltd in acute pain (2 arms). Primary endpoints: Rate of eligible patients consenting to participate at 12 months, Rate of patients adhering to the study protocol in terms of medication intake at 7 days and 2 more. Started May 2024; status: completed.
02
Drugs
Placebo-COD Research Private Ltd
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT06408519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06408519.